Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 5,208 | 4,382 | 5,533 | 5,062 | 2,874 |
| Gross Profit | 5,208 | 4,382 | 5,533 | 5,062 | 2,874 |
| Operating Expenses | 29,350 | 27,516 | 27,510 | 25,530 | 20,687 |
| Operating Income | -24,142 | -23,134 | -21,977 | -20,468 | -17,813 |
| Other Income | 947 | 1,089 | 1,200 | 1,002 | 467 |
| Pre-tax Income | -23,195 | -22,045 | -20,777 | -19,466 | -17,346 |
| Income Tax | -235 | -85 | -125 | -66 | -152 |
| Net Income Continuous | -22,960 | -21,960 | -20,652 | -19,400 | -17,194 |
| Net Income | $-22,960 | $-21,960 | $-20,652 | $-19,400 | $-17,194 |
| EPS Basic Total Ops | -20.89 | -20.17 | -18.73 | -18.37 | -18.73 |
| EPS Basic Continuous Ops | -20.77 | -20.00 | -18.83 | -18.37 | -18.59 |
| EPS Diluted Total Ops | -20.89 | -20.17 | -18.73 | -18.37 | -18.73 |
| EPS Diluted Continuous Ops | -20.77 | -20.00 | -18.83 | -18.37 | -18.59 |
| EBITDA(a) | $-24,269 | $-23,417 | $-22,568 | $-21,007 | $-18,041 |